



A 10-year laboratory-based study
J. M. McAnerney, S. Johnson, B. D. Schoub
Respiratory virus isolates made at the National Institute for
Virology from 1982 to 1991 were studied. An active virus
surveillance programme, 'viral watch', which recruits
throat swab specimens from a network of monitoring
centres - mainly in the Witwatersrand and Vereeniging
area with one centre in Middelburg - that represent a
cross-section of the population, provided 68% of the
specimens and 74% of the isolates, with an isolation rate
of 25,5%. This was significantly higher than that of routine
specimens (17,7%). Of the 966 isolates, influenza viruses
accounted for 527 (54,7%), para-influenza for 122 (12,6%),
respiratory syncytial virus for 34 (3,4%) and adenovirus for
106 (11,0%). Influenza viruses showed a definite seasonal
peak between June and August whereas the other viruses,
although they showed a winter predominance, were
isolated throughout the year. An active virus surveillance
programme is particularly valuable in monitoring
respiratory virus epidemiology in the population.
S Atr Med J 1994; 84: 473-477.
Various methods have been used for disease surveillance,
including the reporting of notifiable diseases as well as
laboratory-based, hospital-based and population-based
surveillance.' Monitoring of respiratory tract infections has
been carried out by means of some of these same
methods;" as well as general practitioner networks;
morbidity reports and reports of school and work
absenteeism.s A combination of two or more of these
methods has been found to be more precise than any single
method alone.'" For detecting outbreaks of disease and
characterising the aetiological agent, laboratory-based
surveillance has been shown to be a useful too!.'
In order to improve the monitoring of respiratory disease,
especially influenza, a 'viral watch' surveillance programme
was started at the National Institute for Virology (NIV) to
recruit suitable specimens for isolation of respiratory viruses
from patients with respiratory tract infection. Similar
programmes have been used in Belgium7 and France.·
This paper describes 10 years of continuous monitoring of
respiratory virus isolates from actively recruited specimens
from the viral watch programme as well as from respiratory
specimens routinely sent in to the NIV for virus isolation.
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Materials and methods
Respiratory specimens received at NIV for isolation of
viruses between 1 January 1982 and 31 December 1991
were reviewed. Specimens submitted with a diagnosis other
than respiratory infection, e.g. meningitis, were excluded
from the study. Respiratory specimens consisted of throat
swabs, tracheal aspirates, bronchial lavages, lung biopsies
and sputa. Throat swab specimens were specifically
recruited from 16 viral watch centres which represent a
cross-section of the population including all race, age and
socio-economic groups. Fifteen of these centres are situated
in the Witwatersrand and Vereeniging area and one in
Middelburg, Transvaal, and comprised general practitioners,
paediatric outpatients, a mine hospital, factory workers,
university students, and staff at a hospital as well as at the
NIV. A maximum of two specimens per week was accepted
from each centre. A specifically designed specimen label
was provided to accompany the specimen.
All specimens were inoculated into both embryonated
chicken eggs and cell cultures. Positive influenza isolates
were typed by haemagglutination inhibition and sent for
confirmatory typing to the World Influenza Centre, National
Institute for Medical Research, Mill Hill, London.
Results
In this study 4 133 specimens received between 1982 and
1991 were reviewed; the number per year ranged from 218
to 525 (median 456). Three thousand five hundred and
seventy (86,4%) were throat swabs, 261 (6,3%) tracheal
aspirates, 104 (2,5%) lung biopsy specimens, 100 (2,4%)
bronchial lavage specimens and 98 (2,4%) sputum
specimens. Viral watch specimens accounted for 2 811
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Fig. 1. Proportion of viral watch specimens.
A total of 966 viruses was isolated during the 10-year
period, the number per year varying from 46 to 147 with a
mean isolation rate of 23,4%. Table I shows the isolation
rate for each kind of specimen. The isolation rate for viral
watch specimens was significantly higher (P < 0,0001) than
that for throat swabs received from other sources (Table 11).
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Diagnoses provided for 852 (82,2%) of the patients with
positive isolates were influenza, upper respiratory tract
infection, pneumonia, bronchiolitis, croup and tonsillitis!
pharyngitis. The viruses isolated were identified as influenza
(527; 54,6%), paramyxoviruses (169; 17,5%), adenovirus
(106; 11,0%), herpesviruses (91; 9,4%), enteroviruses
(70; 7,2%) and reoviruses (3; 0,3%) (Fig. 2).
last for more than 14 weeks, Le. in 1989 the first and last
isolates were made on 10 April and 16 October respectively.
In 1983 a substantial number of isolates were made
between the middle of September and the end of November,
some 6 weeks after the cessation of normal winter activity.
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1983 AH,N, A/Hong Kong/2/82
AH,N2 A/Philippines/2/82
1984 AH,N, A/Chile/1/83
A HaN2 A/Philippines/2/82; A/Belgiurn/2/81
B B/USSR/100/83
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Table I. Isolation rate (0/0) per type of specimen
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Fig. 2. Type of isolate, 1982 - 1991.
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Influenza viruses were further typed as influenza A H,N,
(193), influenza A HaN2 (198), influenza B (120) and influenza
C (16). Influenza A H,N, and HaN2 , as well as influenza C,
were detected in 7 of the 10 years studied and influenza B in
8. Only 1 subtype of influenza (A H,N,) was detected in 1987
and all 3 subtypes were detected in 1984, 1985 and 1989.
The serotypes and strains are shown in Table III and Fig. 3.
Although influenza viruses were isolated sporadically
throughout the year, influenza showed a distinct seasonal
pattern, with the first isolates usually appearing by mid-
June. The mean duration of the 'season' of influenza
isolation was 12 weeks. Only in 1 of the 10 years studied did
the 'influenza season' start before the middle of May and
Fig. 3. Influenza serotypes, 1982 - 1991.
Ages were known for 458 (89,6%) of the 511 patients from
whom influenza A or B was isolated. The age distribution for
all 3 subtypes was similar with ranges of 1 month to 67
years (median 18 years) for influenza A H,N" 1 month to 79
years (median 13 years) for A HaN2 and 4 months to 57 years
(median 16 years) for influenza B. The vast majority of
influenza isolates (510/527; 96,8%) were made from throat
swabs. Diagnoses were known for 513 (97,3%) patients. The
most common diagnosis was influenza (47,2%) followed by
upper respiratory tract infection (URTI) (34,5%).
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Adenoviruses were isolated throughout the year and no
seasonal pattern was observed (Fig. 7). Ages were known
for 91 patients and ranged from 1 month to 60 years
(median 18 months), with the largest group (35; 38,5%)
under 1 year of age. The majority (75; 70,8%) of isolates
were made from throat swabs, 17 (16,0%) from tracheal
aspirates, 10 (9,4%) from post-mortem lung biopsies and 4
(3,8%) from sputum specimens. Diagnoses were known for
74 (70%) patients of which the largest group (26; 35,1%)
had URTI, followed by 21 (28,4%) with tonsillitis/pharyngitis.
Fig. 4. Seasonal distribution of influenza viruses.
Of the 122 parainfluenza viruses isolated type 3 was the
most common, Le. 101 (82,8%). Isolates were made
throughout the year but the majority (62,3%) were isolated
during the months April to September. Respiratory syncytial
virus (RSV) was only isolated occasionally between January
and March, with 29/34 (85,3%) being isolated between April
and August (Fig. 5). Although for both parainfluenza and
RSV the majority of patients were aged under 5 years, the
proportion was significantly higher for RSV (87,1 %) than
parainfluenza (60,9%) (P = 0,0123) (Fig. 6). The majority
(124/156; 79,5%) of parainfluenza and RSV isolates were
made from throat swabs, with 25 (15%) from tracheal
aspirate and bronchial lavage specimens and 2 isolates from
post-mortem lung biopsy and 5 from sputum specimens.
Two of the 5 measles virus isolates were made from tracheal
aspirates, 1 from a post-mortem lung biopsy and the
remaining 2 from throat swabs. The 8 mumps virus isolates
were all made from throat swabs. The diagnosis was given
for 83% of patients with parainfluenza and 74% of those
with RSV isolates. The spectrum of diagnoses for
parainfluenza and RSV was similar, with URTI responsible for
the largest group (25,4%), followed by pneumonia (23,0%).
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Twelve herpesviruses were identified as cytomegalovirus
and 79 as herpes simplex virus (HSV) (50 HSV type 1, 6 HSV
type 2 and 23 not typed). Isolates were made throughout the
year and no seasonal pattern was detected (Fig. 7).
Of the enteroviruses, 9 were identified as Coxsackie A,
24 as Coxsackie S, 13 as echovirus and 13 as poliovirus;
11 were not identified further. Although there was no clear
seasonal pattern few isolates (17170; 24%) were made
during the winter months (Fig. 7).
Fig. 5. Seasonal distribution of paramyxoviruses.
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Discussion
Respiratory infections are an important cause of morbidity
and mortality in the developing world. Monitoring of
respiratory disease is important in the early recognition of
influenza outbreaks and the determination of circulating
strains. The cornerstone of influenza surveillance has been
the monitoring of deaths due to pneumonia and influenza.
However, with this method, an outbreak may be in progress
for several weeks before it is identified." Laboratory-based
surveillance has proved useful in detecting Widespread
outbreaks of disease' and in obtaining early isolates of
influenza virus." Surveillance only of routine specimens sent
to the laboratory would be of less value as shown in our
study where 68% of the specimens and 74% of the isolates
originated from the viral watch programme. Laboratory-
based data are not really representative and are more
qualitative than quantitative in nature; this precludes
estimation of the rate of attack in the general population.
However, even sporadic reporting of individual cases can
uncover unusual disease activity.' When very few specimens
are received, the chances of detecting an outbreak of a
respiratory illness decrease as the respiratory viruses are in
permanent circulation and a single isolate would not indicate
an outbreak.
The NIV forms part of the global network of WHO National
Institutes of Influenza established to collect and analyse
influenza data and strains throughout the world" in order to
identify and characterise strains in circulation and detect
antigenic variants in order to design the vaccine
composition." For this purpose the viral watch system has
proved extremely valuable. During the 10-year period only
11 % of annual influenza isolates came from routine
specimens.
Participating doctors in the viral watch programme are in
a good position to collect suitable specimens; this
maximises the virus isolation rate. From time to time
changes have been made to include different geographical
areas and different types of centres. Although the number of
specimens submitted by each viral watch centre was limited
so as not to overburden the laboratory, specimens were
received throughout the year. Continual contact with doctors
at these centres was necessary. This ensured that the
specimens were sent and allowed feedback to the doctors
about the isolates. Ages and diagnoses were available for all
viral watch specimens, whereas ages were only available for
132 (53,2%) and diagnoses for 134 (54,0%) routine
specimens. The data, however, remain skewed as only
patients attending doctors were included and were thus not
representative of the general population. However, the
presence of viruses in the community and the period of
circulation of these viruses can be determined."
The pattern of respiratory virus isolation was similar for all
10 years, with influenza starting on average by mid-June
and lasting a mean of 12 weeks. The same subtypes had
usually been isolated in the northern hemisphere during the
preceding winter season, although the strains often differed.
In the 1989/90 season influenza A/Shanghai/11 /87 (HaN,)
caused the most severe influenza season of the past decade
in Europe'o whereas only mild to moderate influenza activity
was experienced in the Witwatersrand, with the majority of
the influenza A HaN, isolates being typed as A/Beijing/
352/89. Only one major outbreak of influenza" occurred
during the 10-year period studied. The herald wave
phenomenon, Le. the detection of a new strain of influenza
which causes a minor wave of disease at the end of an
epidemic and is then followed by major epidemic activity in
the following season," does not seem to hold true in this
study. Only in 3 years were the last strains isolated in one
season and the first strains isolated the next, Le. 1982, 1986
and 1989, and these did not cause major epidemic activity
the following year.
Of the three influenza subtypes circulating throughout the
world, influenza A H,N, circulated prior to 1957, with the last
major epidemic in 1953; the subtype disappeared and o~ly
reappeared in 1977.' Influenza A H,N, has been shown to
have a specific age attack rate, with fewer than 5% of
patients having been born before 1950.' In this study,
however, where ages were known for 166/193 patients with
influenza A H,N" 23 (13,9%) were born before 1950. .
Previous studies have shown that influenza A was qilly
isolated from children over 6 months of age3 whereas we
found that 13 (3,7%) of the patients with influenza A isolates
were aged less than 6 months. Influenza A H,N, has also
been shown to occur less frequently than A H3N, in children
younger than 6 years, especially in those less than 2 years
of age." However, during the 10-year period, similar
proportions for both A H,N, and A H3N, were found in the
less than 6 (25,3% and 24,4%) and less than 2 (8,4% and
10,9%) year age groups. .
Unlike in other studiesa,s,13 RSV was not the most frequent
isolate from the specimens of children; however, the majority
of the children in this study presented with URTls. Of the
328 children younger than 5 years, 31,7% presented with
lower respiratory tract infections and of these only 12
(11,5%) had positive RSV isolates. (The low isolation rate for
RSV in this study may be partly due to the fact that although
all specimens were taken early in the illness and placed in
viral transport medium, in many instances the specimens
were in transit for up to 48 hours.) With only sporadic
isolates of RSV in the late summer/autumn months, the
characteristic winter distribution" was also evident in this
study, with a slightly more variable seasonality for
parainfluenza, although the majority of isolates were also
made during the winter months. During the 10 years, RSV
was never isolated between September and December.
Laboratory-based surveillance provides data on the type
of viruses circulating. However, the viral watch programme
augmented this surveillance, provided more specimens, a
higher isolation rate and more detailed epidemiological data.
We would like to express our sincere thanks to the
doctors who participated in our viral watch programme and
to the laboratory staff for technical assistance.
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Rheumatic fever
prophylaxis in South Africa
- is bicillin 1,2 million
units every 4 weeks
appropriate?
E. D. Daniels, D. Mohanlal, J. M. Pettifor
Rheumatic fever is a major health problem in South Africa.
Although intramuscular benzathine penicillin (bicillin)
1,2 million units (MU) every 4 weeks is widely used for
secondary prophylaxis, studies in other countries have
shown a recurrence rate of 3 - 8% over 5 - 6 years in
patients on this regimen. It has been recommended that
serum penicillin concentrations should be maintained
above 0,02 mg/ml to prevent such recurrences. The World
Health Organisation (WHO) and the American Heart
Association have recommended since 1988 that patients
in high-risk areas for the development of rheumatic fever
should receive benzathine penicillin 1,2 MU every 3 weeks
rather than every 4.
The aims of this study were, firstly, to determine the
prevalence of serum penicillin concentrations below 0,02
j.Jg/ml in rheumatic fever patients on benzathine penicillin
1,2 MU 4-weekly and, secondly, to study the effect of
increasing the dose to 1,8 MU 4-weekly in patients with
subtherapeutic concentrations.
Forty-five of 51 rheumatic fever patients (88%) in this
study on benzathine penicillin 1,2 MU 4-weekly had low
serum penicillin concentrations « 0,02 j.Jg/ml) at the end of
the 4th week after the injection. Penicillin was detected in
the urine of 30 of the 45 patients (67%) with low
concentrations, suggesting that such patients have tissue-
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bound penicillin which might be important in preventing
rheumatic fever. The 15 patients (33%) with subtherapeutic
serum penicillin concentrations and no detectable
penicillin in the urine could be at very high risk for
recurrent attacks of rheumatic fever.
Fourteen of 29 patients (48%) given the higher dose of
benzathine penicillin (1,8 MU 4-weekly) had
subtherapeutic serum penicillin concentrations at the end
of the 4th week after the injection, but in all 29 penicillin
was detected in the urine.
Review of our present policy of secondary prophylaxis
for rheumatic fever is necessary. Concentrated
preparations of benzathine penicillin (600 000 Ulml) are
not available in South Africa; administration of a higher
dose (1,8 MU) 4-weekly would therefore require a double
injection, which could affect compliance adversely. We
recommend that rheumatic fever patients in our area
should receive benzathine penicillin 1,2 MU 3-weekly as
recommended by the WHO until strategies for secondary
prophylaxis have been evaluated further.
S Atr Med J 1994; 84: 477-481.
Rheumatic heart disease is the most common form of
acquired cardiac disease in children worldwide. The
prevalence of rheumatic fever and rheumatic heart disease
in schoolchildren has been estimated to be less than 1/1 000
in developed countries and 11 - 22/1 000 in developing
countries.' In 1972 McLaren et aJ.2 reported a prevalence of
rheumatic heart disease of 6,9/1 000 in 3 - 18-year-old
children in Soweto, Johannesburg. Edginton and Gear" list
rheumatic heart disease among the top 10 causes of death
in the 15 - 24-year age group in South Africa. The financial
burden on the country is reflected in the estimated costs
(approximately R40 million annually) for valve replacement
surgery at six major South African centres for the 5-year
period 1982 - 1987.'
Secondary antibiotic prophylaxis against group A
l3-haemolytic streptococcus (GABHS) infection in patients
with rheumatic heart disease will not only prevent
recurrences but will improve healing of carditis' Recurrent
attacks of rheumatic fever usually result from non-
compliance with prophylaxis. However, a disturbing
recurrence rate of 3 - 8% over 5 - 6 years has been
recorded in patients known to be compliant with the regimen
of intramuscular benzathine penicillin (bicillin) 1,2 million
units (MU) every 4 weeks.'-' Low as this rate may be, it is
unacceptable because these patients run the risk of
increased cardiac damage despite conscientiously arriving
every month (often at great inconvenience) for treatment
which is quite painful.
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